News Tag: Corporate Information

The acquisitions underline Helena’s strong commitment to iZafe Group’s operations and her confidence in the company’s continued development and growth. Following the transactions, Helena’s total holding amounts to 297,328 B-shares.

“I see how hard our team works every day, how quickly we are developing, and the strong potential in our market. We are in a very exciting phase, and for me, it feels natural to increase my ownership when I see the direction and opportunities ahead of us.” says Helena Kolvik, Business Unit Manager at iZafe Group.

Sweden – Growing customer base, new pilots and increased visibility
We now have more than 20 Swedish municipalities using or actively testing Dosell – and interest continues to grow month by month. In October,
Several municipalities signed new pilot agreements during the month, scheduled to begin in November and December. We are also seeing increased interest from nursing homes (SÄBO), where Dosell is viewed as a concrete solution to reduce medication errors and strengthen residents’ independence.

To meet the growing demand, we have recruited two new salespeople focusing on the municipal and private care sectors. Their role is to support implementation, follow up on leads and drive continued expansion.

Meanwhile, the ADDA procurement process – Sweden’s first national framework agreement for medication dispensing robots – is now in its final phase. The estimated annual contract value of SEK 200 million highlights a maturing market and confirms Dosell’s strong position heading into 2026.

The Netherlands – Integration and continued growth
Following the acquisition of Thuisapparatuur Nederland B.V., our focus has been on fully integrating operations into the Group. The Dutch team has maintained close customer engagement, participated in fairs, onboarded a new customer, and increased volumes with existing ones. We have also initiated new platform integrations and are working on improved packaging to further enhance the user experience.

Dosell is currently in use across more than 30 care organisations in the Netherlands – Europe’s most mature market for medication dispensing robots. Yet growth potential remains significant: over 600,000 people in the country receive medications in pouch packaging, but only around 17,000 medication dispensers are currently in operation. Our solution, developed in this complex environment, is now both technically advanced and highly user-friendly – positioning us strongly to lead the next phase of market growth.

Finland – Strong interest and technical readiness
Together with our partner AddSecure, we have completed all preparatory work ahead of the rollout to existing customers. This includes full integration with the leading UMO/Enovation care platform, training materials, system flows, and pilot testing.

Interest from both private care providers and public welfare areas is very high – Dosell is seen as a concrete and sought-after solution to improve adherence, reduce deviations, and free up time for care staff.
Next week, we will participate in Finland’s largest home care and assisted living trade fair – KOPA 2025 – together with AddSecure, further strengthening our local presence and enabling key customer dialogues.

Spain – Pharmacy launch with Ti Medi
In Spain, we are taking the next step together with our partner Ti Medi, who collaborates with over 1,600 pharmacies that serve more than 200,000 patients receiving pouch-packed medications.

In November, we are launching an initial pilot across approximately 10 pharmacies where Dosell will be physically available in-store. Customers can easily bring Dosell home and register their subscription digitally. The launch will be supported by Black Friday and holiday campaigns, with the goal of establishing a new, safe, and accessible solution for home-based medication management.

The concept of medication dispensers is new to the Spanish market, but with Ti Medi as our partner, we have strong local reach and the right channels to engage both patients and families.
They have also begun promoting the concept in their operations in Portugal and France, where Dosell is now being introduced via trade fairs and local initiatives. The next step will be Italy, where a similar rollout is planned.

Finance & Forecast – On track
Our financial performance in Q3 shows that we’ve established a stable and scalable business model based on recurring revenues. At the beginning of Q4, our ARR reached approximately SEK 7 million – a fourfold increase since the start of the year – and we remain on track to meet our target of SEK 10 million ARR during Q4. The recently acquired Dutch company generated approximately SEK 1 million in revenue during Q3, which was not consolidated but will contribute from Q4 onwards.

At the same time, we’ve improved our cost structure, strengthened cash flow, and created a better foundation for long-term profitable growth. EBITDA improved significantly compared to the same period last year, despite lower overall revenues – a clear sign of increased operational efficiency.

Looking ahead – Key focus areas through year-end
We are now entering the most intense period of the year. Our focus for November and December includes:

• Finalisation and submission of the ADDA procurement (deadline: 10 November)
• Onboarding of additional municipalities in Sweden
• Expanded outreach to nursing homes (SÄBO) and broader engagement with the private care sector
• Continued product demos and pilot discussions with municipalities
• Ongoing integration and coordination of operations in the Netherlands
• Launch and evaluation of the pharmacy pilot in Spain
• Continued dialogue with new potential partners across Europe

Thank you for your trust – building the future of medication management
We are still a small team – but a highly dedicated one. With a stronger offering, growing recurring revenues, and rapid international expansion, we are entering 2026 with the right conditions to continue delivering – both in the market and toward our strategic goals.

Thank you for following our journey.
We’re only just getting started.

The Nomination Committee consists of:

• Patrik Björn, private shareholder and representative of Gästrike Nord Invest AB, with a total holding of 105,800,000 shares (28.97 percent)
• Stefan Wård, private shareholder with 42,454,090 shares (11.6 percent), serving as Chair of the Nomination Committee
• Eva Redhe, private shareholder with 20,034,254 shares (5.5 percent)

In total, the Nomination Committee represents 168,288,344 shares, corresponding to approximately 46.08 percent of the share capital and votes in iZafe Group AB.

The Nomination Committee’s mandate is to propose the composition of the Board of Directors, Board fees, auditor, and the Chair of the 2026 AGM.

“We are very pleased to have an engaged and capable Nomination Committee composed of our largest owners. This strengthens our focus on long term value creation and the company’s continued expansion,” says Anders Segerström, CEO of iZafe Group.

The Nomination Committee begins its work as iZafe Group continues to grow rapidly and strengthen its position in digital medication management, in line with the company’s focus on improving health and well being through innovative solutions.

Shareholders who wish to submit proposals to the Nomination Committee may do so via email to .

At the same time, we are taking over customer relationships, contracts, inventory and three dedicated employees – giving us full control of Europe’s most mature and established market for medication dispensers, where Dosell is already used by over 30 care organizations. The collaboration has already made Dosell more technically advanced and user-friendly – something that now strengthens our ability to expand faster into new markets.

Although the Netherlands has around 17,000 medication dispensers in operation, over 600,000 people receive their medicines via multidose sachets – showing that the market is still only at the beginning of its potential. The acquisition makes us more present, faster and better equipped to take the next step.

ADDA – a breakthrough on the Swedish market
Sweden’s first national procurement for medication dispensers has now been published by ADDA. Estimated annual value: SEK 200 million. This creates a clear structure for municipalities to implement medication dispensers – and confirms that the market is maturing.

Several municipalities have already expressed interest in starting pilots with Dosell this autumn, to later call off via the new framework agreement. Even though allocation is yet to come, this is an important development that increases Dosell’s visibility and creates better conditions ahead of 2026.

Sweden – more municipality launches and growing interest
Two new municipalities launched Dosell in September. A third launch has been moved to October – along with two additional municipality launches. We are careful to ensure that every start-up takes place only when the entire organization is ready, to achieve the best possible results and happier users.

We have conducted 10 digital presentations and are in contract discussions with two new municipalities. We also held our first international Partner Day in Stockholm with participants from five countries – providing valuable insights and strengthened collaboration across markets.

Finland – easier implementation thanks to new integration
Our partner AddSecure has quickly established Dosell as a relevant solution in the Finnish market. Through a new integration with UMO/Enovation – one of the most widely used care platforms in Finland – Dosell can now be implemented without replacing existing systems. This has generated strong interest from both private and municipal actors.

Italy – new legislation opens the market
Dosell requires medicines to be packaged in multidose sachets – something that until now has only been legal in certain regions of Italy. After several years of work by our partner, September brought a historic breakthrough: it is now legal to package medicines in multidose sachets throughout Italy.

This is a crucial prerequisite for Dosell to be launched widely in the country. Even though it will take time before large volumes build up, we now have for the first time the opportunity to truly establish ourselves in a market with great future potential.

Looking ahead – an intense quarter awaits
We are now entering the most eventful quarter of the year. In October we will focus on:

• Submitting to the ADDA procurement (deadline 30 October)
• Three new municipality launches plus a pilot with 20 Dosell units (with potential to scale to 150–200)
• 10 new presentations for Swedish municipalities
• Participation at Äldreomsorgsdagarna in Stockholm with our partner Zafe Care Systems AB
• Dialogue with a major private operator within elderly care (SÄBO)
• Finalizing agreements with two new potential partners in Europe
• Continued technical development in the Netherlands, including new integrations with platforms used by care providers
• Increased focus on customer satisfaction in the Netherlands, aiming to further strengthen deliveries, onboarding and support for both existing and new customers

We’re building something big – together
We are still a small team – but a very dedicated one. Through the acquisition in the Netherlands, we have strengthened our organization, increased our ARR and improved our profitability.

As communicated in connection with the acquisition, we now estimate that our ARR target of SEK 10 million can be reached already in Q4 2025 – earlier than our previous forecast. At the same time, both ADDA and the acquisition in the Netherlands lay a strong foundation to accelerate reaching future targets.

Thank you for following our journey.

We’re only at the beginning.

“The fact that the entire board has chosen to increase its ownership is a clear signal of our shared commitment and confidence in iZafe’s strategy and future. We see great potential in the company’s continued development and, through our investments, want to demonstrate that we fully support the path that has been set out,” says Richard Wolff, Chairman of the Board of iZafe Group.

Continued Strong Interest in Sweden
Interest from Swedish municipalities remains high. In August, we conducted 17 digital demos – with recurring comments such as:

“It’s truly so user-friendly!”
“This fits many more areas in the municipality than what we’re currently working with.”

We’ve been actively preparing for the launch of three new municipalities going live in September. At the same time, we’re seeing that many municipalities are now awaiting the national ADDA procurement – Sweden’s first coordinated framework for medical dispensers, with an estimated value of 80 MSEK annually. We strongly believe this will act as a catalyst for the market and help accelerate the adoption of medical dispensers throughout Sweden.

Finland: Pilot Launch in September
Our new partner in Finland, AddSecure Smart Care Oy, has made significant progress during August. A pilot is set to begin in mid-September. This is an important milestone for Dosell as a company and marks a strong start to our establishment in Finland.

The Netherlands: Rising Demand and Rapid Deliveries
The holiday season is over – and the need for scalable medication management solutions in the Netherlands has become even more evident. In August, several care organizations decided to bring forward their planned Dosell deployments in direct response to increasing staff shortages in elderly care.

Thanks to strong local presence, experience from earlier rollouts, and access to stocked devices, our partner was able to meet the demand swiftly.

New Software and a Smarter Loading Process
Over the summer, we completed and began rolling out a new software version of Dosell. It includes improvements in stability, performance, and user experience – especially valuable in large-scale implementations.

We’ve also developed a simplified loading process. This enhances our ability to integrate into existing infrastructures and strengthens our readiness to scale in new markets.

Prepared for September – and the Rest of the Year
There’s a lot ahead:

• Three municipalities go live in September
• More demos and procurement processes
• Dosell’s first Partner Day
• Meetings with potential new partners
• Trainings for upcoming launches

We look forward to reporting a strong September in the next monthly update – and thank you for your continued trust!

A Stress Test in the Netherlands
In July, our network provider experienced two major service outages, which temporarily impacted our operations – particularly in the Netherlands. It was a testing situation for both us and our partners. However, thanks to fast and clear communication, effective crisis management, and close collaboration, we were able to minimize the impact for our users.

As our partner in the Netherlands put it: it was a tough day, but also a clear proof that we have the right product, the right people, and the right mindset to get through even major challenges. It further strengthens our confidence in the future.

We are now working intensively to build increased redundancy to reduce the risk of future network disruptions. It’s also worth highlighting that users connected via WiFi were not affected at all – demonstrating the value of having multiple connectivity options.

Stable Usage and ARR Growth
As expected, we didn’t see a significant increase in the number of units during July. The vacation period affects many operations, especially in Sweden. But we are pleased to report that:

• The Netherlands saw a 5.5% increase in the number of units – even during the holiday period.
• ARR increased during July, thanks to sales of additional services and upgrades.

This confirms that Dosell is not just being installed – it is continuously used and creating value.

Progress in Sweden
Despite the summer slowdown in many municipalities, our momentum remains strong:

• We won a direct procurement where a municipality, after a successful pilot, is switching from their previous supplier to Dosell and placing an order for 30 units.
• 3 new municipalities will launch in August – continuing our geographic expansion.
• Interest remains high – 15 digital demonstrations are already booked for August with Swedish municipalities.

Comments like “I hear nothing but that it works great” are strong indicators of the stability and value Dosell provides.

Spain – Next Step Toward Wider Rollout
In Spain, our partnership with Ti Medi continues to gain attention. In July, La Vanguardia published an article highlighting how Ti Medi is now taking the next step by working directly with pharmacy chains to scale the use of Dosell.

That said, it’s important to recognize that the concept of medication dispensers is still new to the Spanish market, and it will take some time for both users and healthcare providers to fully appreciate its benefits. In countries like the Netherlands and across the Nordics, the solution has gained broader adoption and is already seen as a natural part of future medication management.

We’re confident that Spain will get there too – and once it does, we expect a classic “ketchup effect.” Ti Medi has a strong presence, a clear plan, and is working methodically to build understanding and demand. This makes them the ideal partner to drive development forward in this important market.

Read the article: La Vanguardia – Ti Medi

Finland – New Market with a Strong Partner
In July, we signed an agreement with AddSecure Smart Care Oy, who will now launch Dosell in the Finnish market. They have already placed their first order and have an ambitious plan for the autumn. This is an important piece in our Nordic expansion, and we look forward to a strong collaboration.

Strong Engagement from Our Shareholders
We are very pleased that so many shareholders have taken advantage of our exclusive offer – where shareholders can receive a Dosell device with a free subscription for a limited time. The offer has already generated many registrations, which shows strong interest and engagement. We hope even more shareholders will take the opportunity to try Dosell and experience the value it creates – both for individuals and society.

Read more and register here: https://dosell.se/aktieagarforman/

Charging Up for a Strong Autumn
Our team has had a well-deserved break during the summer – something that was much needed after an intense start to the year. Although many had to step in briefly during their holidays due to our small and committed team, the recovery time has been important.

Now, we are fully recharged and ready for an eventful autumn.

We have a clear plan, strong partners, and a goal that feels more within reach than ever: to reach SEK 10 million in ARR before the end of the year.

Thank you for following our journey – and thank you to all shareholders, customers, and partners who make it possible.

Through this partnership, iZafe Group gains access to a well-established partner with extensive reach in the Finnish welfare technology sector. AddSecure Smart Care Oy brings many years of experience delivering digital safety solutions to municipalities and home healthcare providers – making them an ideal partner for introducing Dosell in Finland.

Finland represents a market with growing demand for safe, efficient, and user-friendly medication management in the home. By combining proven technology with strong local presence, the partnership creates a solid foundation for long-term commercial success.

“This agreement gives us a strong foothold in Finland and opens up significant growth opportunities. We look forward to working with AddSecure to improve medication adherence and safety for even more people,” says Anders Segerström, CEO of iZafe Group.

June was marked by strategic initiatives and a clear forward focus. The summer months are traditionally quieter, which is also reflected in our budget, but we remain firmly on track toward our stated goal of reaching 10 MSEK in ARR by year-end. Despite seasonal effects, the number of dispensings increased by 5% in June compared to May – a clear indication that Dosell usage continues to rise as more units are deployed and used consistently.

We carried out a directed share issue that brought approximately 10 MSEK into the company, strengthening our position to continue growing in Sweden and across our prioritized international markets.

We also launched an exclusive offer for our shareholders – for a limited time, shareholders can receive a Dosell with a free subscription. This is an opportunity to try the product firsthand, contribute to better medication management, and become an ambassador for tomorrow’s solution.
We’ve already received enthusiastic responses and interest in the offer, which is very encouraging. I truly hope even more shareholders take this chance to try Dosell and experience the value it delivers – both for individuals and for society.

Read more and register here: https://dosell.se/aktieagarforman/

Sweden: Summer Pause in Municipalities – But Strong Momentum in Dialogue and Planning
Swedish municipalities are entering a summer period where many processes slow down due to holidays and temporary staffing. This is reflected in a temporarily slower pace, but we’ve taken the opportunity to focus on preparations for the autumn.

In June, we conducted no fewer than 18 digital product demos for municipalities that have shown curiosity and interest. We’ve also been working intensively on fall planning for the launches and pilots scheduled to begin in September.

Feedback from existing customers remains strong – as one put it: “I hear nothing but that it works great!”

Spain: Ti Medi Expands – Strong Media Coverage and Expansion Planning
Our partner Ti Medi continues to expand through the national pharmacy network and has also gained significant media attention. A recently published article in La Vanguardia about their initiative has spread widely and generated additional interest.

The focus now is to continue scaling within Spain – but also to bring Dosell to new countries. Ti Medi is now preparing for launches in both Portugal and France this fall.

The Netherlands: 21% Growth in June – Over 30 Care Organizations in Operation
The Netherlands continues to deliver impressive results. In June alone, the number of active units with our partner grew by 21%, with an additional 21% growth expected in July based on the current pipeline.

Our partner drove more than 300 kilometers in a single week to meet with partners, deliver Dosell units, and identify specific needs in each organization. The Netherlands now has over 30 care organizations using Dosell – clear proof of both the demand and scalability of the solution.

Unlike Sweden, several Dutch organizations choose to launch during the summer. As one partner put it: “We have to start now – we simply don’t have the resources to help our users manage their medication without Dosell.”

At the same time, development of further integrations with other platforms is ongoing, making it easier for new organizations to implement Dosell. Several existing customers are also significantly scaling up their usage volumes.

Other Markets: Rising Interest Across New Regions
We continue to engage in dialogue with several new markets expressing interest in implementing Dosell. The need for safer and more efficient medication management is global – and we see strong potential in scaling our model to more countries.

Thank you for following our journey – and a special thanks to all shareholders engaging with Dosell. Together, we continue shaping the future of medication management.